Minimising young children's anxiety through schools (MY-CATS): protocol for a cluster randomised controlled trial to evaluate the effectiveness and cost-effectiveness of an online parent-led intervention compared with usual school practice for young children identified as at risk for anxiety disorders.
Anxiety
At risk
Children
Cost-effectiveness
Early intervention
Online intervention
Parent-led intervention
Prevention
Schools
Screening
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
16 Feb 2022
16 Feb 2022
Historique:
received:
14
10
2021
accepted:
06
01
2022
entrez:
16
2
2022
pubmed:
17
2
2022
medline:
19
2
2022
Statut:
epublish
Résumé
Identifying and supporting young children who are at risk of developing anxiety disorders would benefit children, families, and wider society. Elevated anxiety symptoms, inhibited temperament, and high parental anxiety are established risk factors for later anxiety disorders, but it remains unclear who is most likely to benefit from prevention and early intervention programmes. Delivering an online intervention through schools to parents of young children who have one or more of these risks could maximise reach. The primary aim of this trial is to evaluate the effectiveness and cost-effectiveness of delivering an online parent-led intervention, compared with usual school provision only, for children (aged 4-7) identified as at risk for anxiety disorders on the basis of at least one risk factor. We also aim to identify the characteristics of children who do and do not benefit from intervention and mechanisms of change from the intervention. The design will be a parallel group, superiority cluster randomised controlled trial, with schools (clusters) randomised to intervention or usual school practice arms in a 1:1 ratio stratified according to level of deprivation within the school. The study will recruit and randomise at least 60 primary/infant schools in England, and on the basis of recruiting 60 schools, we will recruit 1080 trial participants (540 per arm). Parents of all children (aged 4-7) in sampled Reception, Year 1, and Year 2 classes will be invited to complete screening questionnaires. Children who screen positive on the basis of anxiety symptoms, and/or behavioural inhibition, and/or parent anxiety symptoms will be eligible for the trial. Parents/carers of children in schools allocated to the intervention arm will be offered a brief online intervention; schools in both arms will continue to provide any usual support for children and parents throughout the trial. Assessments will be completed at screening, baseline (before randomisation), 6 weeks, 12 weeks, and 12 months post-randomisation. The primary outcome will be the absence/presence of an anxiety disorder diagnosis at 12 months. The trial will determine if delivering an online intervention for parents of young children at risk of anxiety disorders identified through screening in schools is effective and cost-effective. ISRCTN 82398107 . Prospectively registered on Jan. 14, 2021.
Sections du résumé
BACKGROUND
BACKGROUND
Identifying and supporting young children who are at risk of developing anxiety disorders would benefit children, families, and wider society. Elevated anxiety symptoms, inhibited temperament, and high parental anxiety are established risk factors for later anxiety disorders, but it remains unclear who is most likely to benefit from prevention and early intervention programmes. Delivering an online intervention through schools to parents of young children who have one or more of these risks could maximise reach. The primary aim of this trial is to evaluate the effectiveness and cost-effectiveness of delivering an online parent-led intervention, compared with usual school provision only, for children (aged 4-7) identified as at risk for anxiety disorders on the basis of at least one risk factor. We also aim to identify the characteristics of children who do and do not benefit from intervention and mechanisms of change from the intervention.
METHODS
METHODS
The design will be a parallel group, superiority cluster randomised controlled trial, with schools (clusters) randomised to intervention or usual school practice arms in a 1:1 ratio stratified according to level of deprivation within the school. The study will recruit and randomise at least 60 primary/infant schools in England, and on the basis of recruiting 60 schools, we will recruit 1080 trial participants (540 per arm). Parents of all children (aged 4-7) in sampled Reception, Year 1, and Year 2 classes will be invited to complete screening questionnaires. Children who screen positive on the basis of anxiety symptoms, and/or behavioural inhibition, and/or parent anxiety symptoms will be eligible for the trial. Parents/carers of children in schools allocated to the intervention arm will be offered a brief online intervention; schools in both arms will continue to provide any usual support for children and parents throughout the trial. Assessments will be completed at screening, baseline (before randomisation), 6 weeks, 12 weeks, and 12 months post-randomisation. The primary outcome will be the absence/presence of an anxiety disorder diagnosis at 12 months.
DISCUSSION
CONCLUSIONS
The trial will determine if delivering an online intervention for parents of young children at risk of anxiety disorders identified through screening in schools is effective and cost-effective.
TRIAL REGISTRATION
BACKGROUND
ISRCTN 82398107 . Prospectively registered on Jan. 14, 2021.
Identifiants
pubmed: 35168635
doi: 10.1186/s13063-022-06010-8
pii: 10.1186/s13063-022-06010-8
pmc: PMC8848959
doi:
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
149Subventions
Organisme : Kavli Trust
ID : N/A
Informations de copyright
© 2022. The Author(s).
Références
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
J Anxiety Disord. 2013 Oct;27(7):711-9
pubmed: 24135256
BMC Med Res Methodol. 2021 Jul 26;21(1):152
pubmed: 34311695
J Am Acad Child Adolesc Psychiatry. 2014 Jan;53(1):21-33
pubmed: 24342383
Lancet Psychiatry. 2017 Jul;4(7):529-539
pubmed: 28527657
J Affect Disord. 2013 Nov;151(2):618-624
pubmed: 23916305
Pharmacoeconomics. 2012 Aug 1;30(8):729-47
pubmed: 22788262
Aust N Z J Psychiatry. 2018 Feb;52(2):181-191
pubmed: 28831814
Behav Ther. 2013 Jun;44(2):325-37
pubmed: 23611081
J Affect Disord. 2018 Jan 1;225:80-90
pubmed: 28802117
Am J Psychiatry. 2015 Dec;172(12):1207-14
pubmed: 26404420
J Abnorm Child Psychol. 2019 Jul;47(7):1121-1133
pubmed: 30569254
Lancet Psychiatry. 2014 Aug;1(3):185-92
pubmed: 26360730
Eur Child Adolesc Psychiatry. 2017 Jun;26(6):623-647
pubmed: 28054223
Appl Health Econ Health Policy. 2011 May 1;9(3):157-69
pubmed: 21506622
Internet Interv. 2018 Feb 19;12:1-10
pubmed: 30135763
Child Psychiatry Hum Dev. 2020 Oct;51(5):709-720
pubmed: 32157488
J Clin Child Adolesc Psychol. 2014;43(4):579-91
pubmed: 23915200
Child Psychiatry Hum Dev. 2017 Feb;48(1):82-93
pubmed: 27286719
J Consult Clin Psychol. 2016 Jan;84(1):1-14
pubmed: 26460572
BMC Health Serv Res. 2006 Apr 19;6:52
pubmed: 16623946
Prev Sci. 2010 Sep;11(3):263-74
pubmed: 20101464
J Am Acad Child Adolesc Psychiatry. 2009 Apr;48(4):400-403
pubmed: 19242383
J Anxiety Disord. 2017 Dec;52:62-71
pubmed: 29053989
J Consult Clin Psychol. 2005 Jun;73(3):488-97
pubmed: 15982146
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
J Psychopharmacol. 2013 Sep;27(9):761-70
pubmed: 23884863
J Child Psychol Psychiatry. 2015 Mar;56(3):345-65
pubmed: 25649325
BMJ Open. 2021 Apr 20;11(4):e044852
pubmed: 33879487
J Anxiety Disord. 2020 Mar;70:102191
pubmed: 32014832
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
Med Care. 2008 Mar;46(3):266-74
pubmed: 18388841
Child Adolesc Ment Health. 2017 Sep;22(3):118-130
pubmed: 32680383
J Am Acad Child Adolesc Psychiatry. 2005 Oct;44(10):996-1004
pubmed: 16175104
BMJ. 2013 Jan 08;346:e7586
pubmed: 23303884
Cochrane Database Syst Rev. 2020 Nov 16;11:CD013162
pubmed: 33196111
J Child Psychol Psychiatry. 1997 Jul;38(5):581-6
pubmed: 9255702
J Abnorm Child Psychol. 2020 Jan;48(1):57-66
pubmed: 31642030
Value Health. 2013 Mar-Apr;16(2):231-50
pubmed: 23538175
Br J Psychiatry. 2013 Dec;203(6):436-44
pubmed: 23969483
J Consult Clin Psychol. 1994 Feb;62(1):100-10
pubmed: 8034812
Psychol Med. 2019 Apr;49(5):828-842
pubmed: 30017006
J Am Acad Child Adolesc Psychiatry. 2005 Mar;44(3):274-82
pubmed: 15725972
Med Decis Making. 2012 Mar-Apr;32(2):350-61
pubmed: 22016450
Ann Intern Med. 2007 Mar 6;146(5):317-25
pubmed: 17339617
Clin Psychol Rev. 2005 May;25(3):341-63
pubmed: 15792853
J Anxiety Disord. 2017 Jan;45:17-23
pubmed: 27907833
J Child Psychol Psychiatry. 2013 Jul;54(7):780-8
pubmed: 23397984
Br J Gen Pract. 2016 Oct;66(651):e693-707
pubmed: 27621291
J Am Acad Child Adolesc Psychiatry. 2019 Jan;58(1):46-60
pubmed: 30577938
Behav Res Ther. 2010 Nov;48(11):1067-77
pubmed: 20696421
J Am Acad Child Adolesc Psychiatry. 2017 May;56(5):417-425.e1
pubmed: 28433091
Behav Res Ther. 2001 Nov;39(11):1293-316
pubmed: 11686265
Eur Child Adolesc Psychiatry. 2020 May;29(5):649-664
pubmed: 31410579